Newbury Pharmaceuticals AB Logo

Newbury Pharmaceuticals AB

NEWBRY | ST

Overview

Corporate Details

ISIN(s):
SE0015244884
LEI:
549300F7XHU3I8CWL373
Country:
Sweden
Address:
Medicon Village, 223 81 Lund
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Newbury Pharmaceuticals AB is a hybrid pharmaceutical company founded in 2020. It focuses on building and marketing a portfolio of proprietary and licensed specialty prescription drugs and branded products. The company operates primarily in the Scandinavian market, positioning itself as a local alternative to multinational corporations. Its product pipeline is concentrated on providing treatment solutions within key therapeutic areas, including oncology, rare diseases, and neurology.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Newbury Pharmaceuticals AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2018-10-05 13:14
Regulatory News Service
Edison Investment Research Limited: Edison issues outlook on NeuroVive Pharmace…
English 10.7 KB
2017-06-29 13:30
Report Publication Announcement
EQS-News: Edison Investment Research Limited: Edison issues initiation on Neuro…
English 11.1 KB

Automate Your Workflow. Get a real-time feed of all Newbury Pharmaceuticals AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Newbury Pharmaceuticals AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-29 Johan Strömqvist Other Sell 13,564 40,692.00 SEK
2025-04-29 Johan Strömqvist Other Sell 10,400 30,888.00 SEK
2025-04-29 Johan Strömqvist Other Buy 10,200 30,804.00 SEK
2025-04-29 Johan Strömqvist Other Buy 5,000 15,570.50 SEK
2025-04-29 Johan Strömqvist Other Buy 5,000 15,200.00 SEK
2025-04-29 Johan Strömqvist Other Sell 2,436 7,332.36 SEK
2025-04-29 Johan Strömqvist Other Sell 100 305.00 SEK
2024-08-03 Andreas Hedskog Other Buy 200,000 178,000.00 SEK
2024-08-03 Andreas Hedskog Other Other 200,000 N/A
2024-01-22 Alsakali Equity AB Other Buy 4,000 18,920.00 SEK

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK